<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04704414</url>
  </required_header>
  <id_info>
    <org_study_id>BASEC-Nr. 2019-00233</org_study_id>
    <secondary_id>CIV-19-08-029404</secondary_id>
    <secondary_id>10000520</secondary_id>
    <nct_id>NCT04704414</nct_id>
  </id_info>
  <brief_title>Exophthalmometry With 3D Face Scanners</brief_title>
  <acronym>EX3D</acronym>
  <official_title>Exophthalmometry With 3D Face Scanners</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Zurich</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Zurich</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study investigates diagnostic methods to measure eyeball protrusion with a smartphone&#xD;
      face scanner compared to the traditional Hertel exophthalmometer. The study aims to validate&#xD;
      a new reliable, fast and convenient smartphone app to measure the protrusion of the eyeball&#xD;
      in different diseases such as Graves' disease, orbital tumors, orbital fractures or orbital&#xD;
      inflammation, as well as other rare diseases.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      BACKGROUND: Accurate and reproducible measures of abnormal eyeball protrusion are important&#xD;
      for diagnosing different causes of exophthalmos, as well as following patients with Grave's&#xD;
      orbitopathy and retroorbital tumors. The current clinical gold standards for measuring&#xD;
      abnormal eyeball protrusion is the Hertel exophthalmometer, which is prone to reading errors&#xD;
      and inconvenient to use.&#xD;
&#xD;
      OBJECTIVE: The purpose of the EX3D-project is to replace the historic Hertel Exophthalmometer&#xD;
      with a state-of-the-art mobile smartphone app that every ophthalmologist can carry in his&#xD;
      pocket.&#xD;
&#xD;
      METHODS: The investigators developed an accurate and easy to use method for measuring&#xD;
      abnormal eyeball protrusion using the TrueDepth camera of the iPhone 11 in comparison with a&#xD;
      high-resolution 3D scanner as a reference to compare with the Hertel Exophthalmometer.&#xD;
&#xD;
      OUTCOMES:&#xD;
&#xD;
        1. Accuracy and precision of 3D face-scanner and iPhone in comparison to Hertel&#xD;
           Exophthalmometer.&#xD;
&#xD;
        2. Test re-test reliability in comparison to Hertel Exophthalmometer.&#xD;
&#xD;
        3. Inter-operator reliability against Hertel Exophthalmometer.&#xD;
&#xD;
        4. Patients before and after exophthalmos changing treatment.&#xD;
&#xD;
        5. Applicability in daily clinical practice.&#xD;
&#xD;
      BROADER IMPACT: The invention makes exophthalmometry quick, easy and objective. A mobile&#xD;
      smartphone application would replace measurements with the traditional Hertel&#xD;
      Exophthalmometer, which are cumbersome, prone to reading errors and have a poor inter-rater&#xD;
      reliability as well as test-retest reliability.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">August 14, 2019</start_date>
  <completion_date type="Anticipated">December 31, 2022</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <intervention_model_description>Accuracy and precision of smartphone in comparison with 3D face scanner and Hertel exophthalmometer&#xD;
Test-retest reliability&#xD;
Inter-operator reliability&#xD;
Before and after exophthalmos-changing intervention</intervention_model_description>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
    <masking_description>Blinding of the operators of Hertel exophthalmometer for previous measurement results.</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Accuracy of the smartphone face scanner</measure>
    <time_frame>On average 2 weeks</time_frame>
    <description>Accuracy of iPhone exophthalmos measurements (measured in mm for each eye) compared to measure with 3D face scanner and Hertel Exophthalmometer</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Test-retest-reliability of the smartphone face scanner</measure>
    <time_frame>On average 2 weeks</time_frame>
    <description>Repeated measures (measured in mm for each eye) of the same subjects with iPhone 11, Hertel Exophthalmometer and 3D face scanner</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Inter-operator reliability of the smartphone face scanner</measure>
    <time_frame>On average 2 weeks</time_frame>
    <description>Measurement (measured in mm for each eye) of the same patients by 3 different operators</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Smartphone face scanner measures before and after treatment with the smartphone face scanner</measure>
    <time_frame>On average 3 months</time_frame>
    <description>Measurements (measured in mm for each eye) with the smartphone face scanner before and after exophthalmos-changing treatment</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">180</enrollment>
  <condition>Exophthalmos</condition>
  <condition>Graves Ophthalmopathy</condition>
  <condition>Orbital Tumor</condition>
  <condition>Orbital Fractures</condition>
  <arm_group>
    <arm_group_label>Validation of smartphone face scanner</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Validation of smartphone face scanner in comparison to Hertel Exophthalmometer and high-definition face scanner.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Exophthalmos measurement</intervention_name>
    <description>Exophthalmos measurement with iPhone 11 vs Artec Space Spider 3D Scanner vs Hertel Exophthalmometer.</description>
    <arm_group_label>Validation of smartphone face scanner</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Written informed consent&#xD;
&#xD;
          -  Able to cooperate with the study investigations (hearing, comprehension)&#xD;
&#xD;
          -  Exophthalmos (Grave's disease, orbital tumors, orbital inflammation, orbital&#xD;
             fractures, rare causes (congenital, e.g. microphthalmos)&#xD;
&#xD;
          -  health controls&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Unable to sign informed consent&#xD;
&#xD;
          -  Unable to cooperate with the examinations (hearing loss, neurological deficits)&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Ophthalmology Department, University Hospital Zurich</name>
      <address>
        <city>Zurich</city>
        <zip>CH-8091</zip>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Konrad P Weber, MD</last_name>
      <phone>0041442555549</phone>
      <email>KONRAD.WEBER@USZ.CH</email>
    </contact>
    <investigator>
      <last_name>Konrad P Weber, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Switzerland</country>
  </location_countries>
  <verification_date>January 2021</verification_date>
  <study_first_submitted>January 6, 2021</study_first_submitted>
  <study_first_submitted_qc>January 8, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">January 11, 2021</study_first_posted>
  <last_update_submitted>January 10, 2021</last_update_submitted>
  <last_update_submitted_qc>January 10, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">January 12, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Zurich</investigator_affiliation>
    <investigator_full_name>Konrad Peter Weber</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>Hertel exophthalmometer</keyword>
  <keyword>exophthalmos</keyword>
  <keyword>face scanner</keyword>
  <keyword>smartphone</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Orbital Fractures</mesh_term>
    <mesh_term>Eye Diseases</mesh_term>
    <mesh_term>Graves Ophthalmopathy</mesh_term>
    <mesh_term>Exophthalmos</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

